Insulin devices recalled over leak risk, reports of 'serious adverse events'

robot
Abstract generation in progress

Insulet Corporation has issued a voluntary recall of specific Omnipod 5 Pods due to a risk of internal leaks that can prevent full insulin delivery. The company has received 18 reports of serious adverse events, including hospitalizations and diabetic ketoacidosis, linked to high blood glucose levels from under-delivery of insulin. Customers are advised to check their pod lot numbers and request free replacements, contacting Insulet Product Support for assistance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin